Saltar al contenido
Merck

Inhibitory effect of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy.

European journal of pharmacology (2004-01-20)
Ju Chi Liu, Tzu Hurng Cheng, Horng Mo Lee, Wen Sen Lee, Neng Lang Shih, Yen Ling Chen, Jin Jer Chen, Paul Chan
RESUMEN

The myocardial protective effects of trilinolein, isolated from the Chinese herb Sanchi (Panax notoginseng), may be related to its antioxidant effects. In the present study, we investigated the effects of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy. Cultured neonatal rat cardiomyocytes were stimulated with angiotensin II, [3H]leucine incorporation and the beta-myosin heavy chain promoter activity were examined. We also examined the effects of trilinolein on angiotensin II-induced intracellular reactive oxygen species generation. Trilinolein significantly inhibited angiotensin II-increased protein synthesis, beta-myosin heavy chain promoter activity, and intracellular reactive oxygen species generation. Antioxidant N-acetylcysteine also decreased angiotensin II-increased protein synthesis and beta-myosin heavy chain promoter activity. Furthermore, trilinolein and N-acetylcysteine decreased angiotensin II- or hydrogen peroxide (H2O2)-activated mitogen-activated protein kinases (MAPKs) phosphorylation, and activator protein-1 (AP-1)- [or nuclear factor-kappaB (NF-kappaB)]-reporter activities. These data indicate that trilinolein inhibits angiotensin II-induced cardiomyocyte hypertrophy and beta-myosin heavy chain promoter activity via attenuation of reactive oxygen species generation.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Glyceryl trilinoleate, ≥98% (TLC), liquid